Jiangsu Hengrui Medicine
600276.SS
#494
Rank
โ‚ฌ39.01 B
Marketcap
6,12ย โ‚ฌ
Share price
-0.62%
Change (1 day)
7.88%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ0.55 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are โ‚ฌ0.55 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ0.53 B4.08%
2021-12-31โ‚ฌ0.51 B4.17%
2020-12-31โ‚ฌ0.49 B46.85%
2019-12-31โ‚ฌ0.33 B1.8%
2018-12-31โ‚ฌ0.32 B22.43%
2017-12-31โ‚ฌ0.26 B34.74%
2016-12-31โ‚ฌ0.19 B24.01%
2015-12-31โ‚ฌ0.16 B29.72%
2014-12-31โ‚ฌ0.12 B83.47%
2013-12-31โ‚ฌ67.53 M23.76%
2012-12-31โ‚ฌ54.56 M1.34%
2011-12-31โ‚ฌ53.84 M12.54%
2010-12-31โ‚ฌ47.84 M40.24%
2009-12-31โ‚ฌ34.11 M41.33%
2008-12-31โ‚ฌ24.13 M-36.14%
2007-12-31โ‚ฌ37.79 M93.62%
2006-12-31โ‚ฌ19.52 M5.35%
2005-12-31โ‚ฌ18.53 M-19.25%
2004-12-31โ‚ฌ22.94 M-56.36%
2003-12-31โ‚ฌ52.58 M15.31%
2002-12-31โ‚ฌ45.6 M-7.67%
2001-12-31โ‚ฌ49.39 M